Tambocor Adverse Reactions

Cardiac: Pro-arrhythmic effects occur but are most likely in patients with structural heart disease and/or significant left ventricular impairment.
In patients with atrial flutter, the use of Tambocor Tablet 100 mg has been associated with 1:1 AV conduction following initial atrial slowing with resultant ventricular acceleration.
This has been seen most commonly following the use of the injection for acute conversion. This effect is usually short lived and abates quickly following cessation of therapy.
Dermatological: There have been isolated cases of photosensitivity.
Gastrointestinal: Nausea and vomiting.
Hepatic: A number of cases of elevated liver enzymes and jaundice have been reported in association with Tambocor Tablet 100 mg treatment. So far this has always been reversible upon stopping treatment.
Neurological: Most commonly giddiness, dizziness and light-headedness which are usually transient.
Ophthalmological: Visual disturbances, such as double vision and blurring of vision may occur but these are usually transient and disappear upon continuing or reducing the dosage.
During long-term therapy, a few cases of peripheral neuropathy, paraesthesia and ataxia have been reported. Extremely rare cases of corneal deposits, pulmonary fibrosis, interstitial lung disease and pneumonitis have also been reported.